Allison Cy Tso

9PUBLICATIONS
41CO-AUTHORS
Regenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)NaturopathyRespiratory diseasesMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 24, 2026
Early mortality with bispecific antibody therapy in RRMM: an IMWG immunotherapy database real-world analysis.

Carlyn Rose Tan, Saad Z Usmani, Andriy Derkach

|Oct 17, 2024
Daratumumab-Based Therapeutic Approaches and Clinical Outcomes in Multiple Myeloma and other Plasma Cell Dyscrasias: Insights from a Nationwide Real-World Chart Review Study.

Allison C Y Tso, Wee Joo Chng, Yeow Tee Goh

|Aug 19, 2024
Variation in immunoglobulin use and impact on survival in myeloma.

Khai Li Chai, Cameron Wellard, Ltp Thao

|Jun 20, 2024
Modeling First-Line Daratumumab Use for Newly Diagnosed, Transplant-Ineligible, Multiple Myeloma: A Cost-Effectiveness and Risk Analysis for Healthcare Payers.

Diana Beatriz Bayani, Yihao Clement Lin, Chandramouli Nagarajan

|May 31, 2024
Tolerability of Daratumumab Amongst Asian Patients with Plasma Cell Dyscrasias - A Single Centre Experience.

Allison C Y Tso, Samuel S Y Wang, Christian A Gallardo

|May 31, 2024
A Retrospective Review of Secondary Hemophagocytic Lymphohistiocytosis (HLH) and Dengue-associated HLH from a Teaching Hospital in Singapore.

Allison C Y Tso, Sanchalika Acharyya, Sing Zern Fong

Pageof 2

Frequent Collaborators

3 joint publications

Kiat Hoe Ong

3 joint publications

Chandramouli Nagarajan

3 joint publications

Melissa G Ooi

2 joint publications

Bingwen Eugene Fan